‏Blood Thinner Lawsuit | Internal Bleeding Lawsuit

‏‏Blood Thinner Lawsuit | Internal Bleeding Lawsuit | Bleeding Side Effects

Side Effects: gastrointestinal bleeding, brain bleeds, blood clots, heart attack, stroke, Severe hemorrhages, Severe internal bleeding, death | Blood Thinner Lawsuits, Internal Bleeding Lawsuits | Pradaxa Lawsuit, Xarelto Lawsuit, Eliquis Lawsuit | ‏Pradaxa Side Effects Lawsuit, Xarelto Side Effects Lawsuit, Eliquis Side Effects Lawsuit

‏Blood Thinner Lawsuit | Internal Bleeding Lawsuit blood-thinner-lawsuit-blood-thinner-lawyer‏Blood Thinner Lawsuit | Internal Bleeding Lawsuit Information: ‏Blood thinners are medications used to treat blood clots and reduce the risk of stroke. At the same time, blood thinners, also known as anticoagulants, can cause serious internal bleeding injuries that require hospitalization or can result in death. The oldest blood thinner on the market is warfarin which is marketed under the brand names of Coumadin and Jantoven. The blockbuster blood thinners Pradaxa, Xarelto and Eliquis are part of a class of drugs called New Oral Anticoagulants. These anticoagulants are marketed as the next generation of drugs to replace warfarin, but they are also at the center of thousands of ‏Blood Thinner Lawsuits | Internal Bleeding Lawsuits mounting in federal and state courts nationwide.

‏The internal bleeding side-effect lawsuits allege blood thinners cause patients to suffer:

  • Severe hemorrhages
  • Gastrointestinal bleeding
  • Brain bleeding
  • Internal bleeding
  • Stroke
  • Blood clots
  • Death

‏Lawsuits involving Xarelto and Eliquis contend their manufacturers failed to warn doctors and patients that these blood thinners do not have an antidote to reverse their effects when significant bleeding occurs.

‏Southern Med Law attorneys are experienced in handling cases involving serious internal bleeding injuries allegedly from Xarelto, Pradaxa and Eliquis. The Firm is offering no-obligation reviews to men and women who have been harmed by blood thinners. If you’ve taken one of these blood thinners and suffered a severe internal bleed, contact Southern Med Law for a free Pradaxa Lawsuit Consultation, Xarelto Lawsuit Consultation or Eliquis Lawsuit Consultation today to speak to one of our firm’s Blood Thinner lawsuit attorneys. Call 205-547-5525 or visit www.southernmedlaw.com for more information.

‏Blood Thinners And FDA Approval

‏Warfarin was the first blood thinner approved by the U.S. Food and Drug Administration (FDA) in 1954 to prevent stroke and systemic embolism. In the event of bleeding, vitamin K is used to reverse warfarin’s effects. The new generation Pradaxa received FDA approval in 2010, Xarelto in 2011 and Eliquis in 2012.

‏Pradaxa

‏Pradaxa Lawsuit | Pradaxa Side Effects Lawsuit | Pradaxa Internal Bleeding

pradaxa-lawsuit-side-effects-lawyer.‏Pradaxa (dabigatran), manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., is in a class of anticoagulant drugs called direct thrombin inhibitors, which attach to clotting agents in the blood and reduce their ability to clot. Pradaxa does not require monthly blood tests and has no known counteracting drug. Patients at the highest risk for abnormal bleedings from using Pradaxa include those who:

  • Are 75 years old or older
  • Have kidney problems
  • Have stomach bleeding, intestine bleeding or an ulcer
  • Take other drugs that increase the risk of bleeding, such as aspirin, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and other blood thinners.

‏In 2016, the FDA approved a reversal agent for Pradaxa called Praxbind (idarucizumab) which is used for emergency surgery or urgent procedures and in life-threatening or uncontrolled bleeding.

‏Xarelto

‏Xarelto Lawsuit | Xarelto Side Effects Lawsuit | Xarelto Internal Bleeding

xarelto-lawsuit-side-effects-lawyerXarelto Lawsuit Information: ‏Xarelto (rivaroxaban) is prescribed to reduce the risk of blood clots, to treat deep vein thrombosis and pulmonary embolism, and to treat atrial fibrillation not caused by a heart valve problem. Xarelto is manufactured by Bayer HealthCare and marketed by Johnson & Johnson’s Janssen Pharmaceutical division. Patients are not required to undergo routine blood tests as do patients taking warfarin. Xarelto, however, does not have a reversal agent.

Xarelto Lawsuits due to serious bleeding side effects

Xarelto lawsuits were beginning to collect in U.S. courts by 2014 after receiving FDA approval in 2011. The Xarelto lawsuits were filed by patients who experienced life threatening bleeding side effects due to the medication. One of the complaints in these Xarelto lawsuits was that the drug maker failed to adequately warn consumers and the medical community about the potential serious bleeding risks associated with the drug, as well as the lack of an effective reversal agent. Xarelto lawsuits laintiffs also dispute the drug companies’ assertions that Xarelto patients don’t require regular blood monitoring, and point to studies that suggest such testing could be beneficial for people using the medication.

In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into a multidistrict litigation, to be litigated in U.S. District Court, Eastern District of Louisiana. Multidistrict litigations are established when it is anticipated that a large number of product liability claims involving similar injuries will be filed over a single product. Such proceedings are intended to conserve the resources of the Court, parties and witnesses, and to avoid duplicative discovery and inconsistent rulings across a large number of similar lawsuits.
(Xarelto Lawsuit Case No. In Re: Xarelto Products Liability Litigation, No. 2592)

‏Eliquis

‏Eliquis Lawsuit | Eliquis Side Effects Lawsuit | Eliquis Internal Bleeding

Eliquis-Lawsuit-side-effects-lawyerEliquis Lawsuit Information: Eliquis (apixaban), made and marketed by Bristol-Myers Squibb and Pfizer, is used by patients at risk of stroke due to atrial fibrillation not caused by a heart valve problem. Patients taking Eliquis may have a higher risk of bleeding if they take other medicines that increase their risk of bleeding, such as aspirin, NSAIDs and warfarin. Like Xarelto, Eliquis does not have a reversal agent.

Eliquis Lawsuits due to serious bleeding side effect

Filed Eliquis side-effects lawsuits allege that plaintiffs who have suffered serious bleeding episodes while taking Eliquis charge that Bristol-Myers Squibb did not do sufficient testing of Eliquis. The Eliquis lawsuit complaints also contend that the company failed to adequately warn that Eliquis, a blood thinner does not have a reversal agent to counteract a bleeding event. In February 2017, the U.S. Judicial Panel on Multidistrict Litigation centralized all Eliquis bleeding lawsuits in the Southern District of New York. The cases will now undergo coordinated pretrial proceedings.
(Eliquis Lawsuit Case No. In Re: Eliquis (Apixaban) Products Liability Litigation – MDL No.2754)
[ http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2754-Initial_Transfer-01-17.pdf ]

The FDA’s approval of Eliquis was based in part on clinical trials known as ARISTOTLE (Apixaban for Reduction in Stroke and Other Thrombotic Events in Atrial Fibrillation), which compared Eliquis, known as apixaban to warfarin. According to Bristol-Myers Squibb, the study’s results showed apixaban was superior to warfarin in preventing stroke or systolic embolism with less bleeding and lower mortality than warfarin. However, statements filed in the Eliquis lawsuits contend Bristol-Myers Squibb committed fraud during the ARISTOTLE trial by concealing side effects which occurred in test users, including a death that was not reported. The FDA sent letters to Bristol-Myers Squibb regarding these and other concerns that had to be addressed prior to Eliquis’ approval.
[ http://www.acc.org/latest-in-cardiology/clinical-trials/2013/07/19/12/07/aristotle ]

Blood Thinner Lawsuits | Pradaxa Lawsuits | Xarelto Lawsuits | Eliquis Lawsuits

‏Thousands of bleeding side-effects lawsuits have been filed nationwide claiming Pradaxa, Xarelto and Eliquis cause gastrointestinal bleeding, brain bleeds, blood clots, heart attacks and strokes. Federal Xarelto lawsuits are centralized in the Eastern District of Louisiana. Similarly, all federal Eliquis lawsuits are consolidated in the Southern District of New York. Pradaxa’s maker, Boehringer Ingelheim announced in 2014 that it would pay $650 million to settle 4,000 Pradaxa lawsuits alleging Pradaxa causes a high rate of heart attacks and uncontrollable bleeding.

‏About Southern Med Law And Filing A Blood Thinner Lawsuit | Internal Bleeding Lawsuit

Led by Dr. François Blaudeau, Southern Med Law has worked hard to develop a strong reputation for aggressively and effectively advocating for people who have been injured by dangerous and defective drugs. If you or a loved one experienced life-threatening bleeding complications from blood thinners, please contact the Firm today to learn more about your legal rights. You can arrange for a free, no-obligation, Pradaxa Lawsuit Consultation, Xarelto Lawsuit Consultation or Eliquis Lawsuit Consultation by filling out our online form, or by calling the office directly at 205-547-5525.